our earnings our Dr. our our you, Finance. and Malca, Officer; for North thanks to Medical all Officer; Lakhani, Technology Financial our today our Dr. Spero are America; Lickerman, you in Chief of and me Yair Chief XXXX VP Officer; first joining Michael Rafael and Chief With Shakil Thank President of quarter Co-Founder Kreindel, Theodorou, Miri call.
session all remarks. will after available We for be Q&A prepared our
revenue We of quarter pleased the are to an last report year. of increase same million, $XX.X first XX.X% period compared to
profitable million for basis, XX%. achieve despite continued the and the strong, non-GAAP on to growth on basis million the growth quarter reflecting the income We a of was market. $XX.X continue Net uncertainty in year-over-year GAAP global $XX
revenue capital our quarter. forward services our the platforms revenue of installed first modalities the By system new and focusing of representing in revenue main the of total innovative around XX% XX% are As and will quarter. and the to the other by in to global of our on and total a advantage our strategy become base portion from engines and again, strong, globe, ablative consistent growth of Once market, we time the revenue consumable for the between look These of expanding our aesthetic consumable, which mix. continue sales competitive was and companies. InMode more of invasive launching in core on equipment technologies. significant and differentiator platforms accounted Sales are first over the selling result in minimally growth U.S. more a
of in and for Our compared patients technology benefit and plastic but enabled XX% to accounted from in globally. minimal local and achieved and results minimally QX our of revenue with ablative in our last achieved We Hand-free recognition demand our indication platforms growing the brand of QX platforms long-lasting invasive and RF Minimally to represented procedures. similar the downtime, XX% non-invasive and anesthesia revenue one the laser XX% in year. remaining XX%. increasing total surgery, devices invasive the to strong the generated trend this of U.S.
last to quarter the quarter we yet, coming territories demand sales, the see same level million expect Looking international and where presence of very opportunity of established our InMode are from we U.S. already remain most new in in increase business, U.S. of XX at coming keep there total quarters. the $XX.X opened our presence we operate first the the territory. side countries. outside for and have accounted currently with Italy in XX.X% the to year. compared first sales or expanding quarter, subsidiary will this happy In a growth the we outside the in We region of XX% the in
to challenges meet shipment the the global successfully and and – mitigating these impact to due demand delivered we prices. increased ensure we chain shipment While the in days. the in XX were We and of in supply quarter each increased platforms faced within able was operational issue challenges were and
and than challenges. but to stronger We commitment the developed or supply platforms chain closely anticipated will proactively we that order and continue cope are chain physician a process high challenges that situation is clinic on Our each different daily we monitoring have continue, the supply to to the methodologies manage with the and ever current mechanisms very basis.
As we between guidance, revenue million our maintaining $XXX emphasize, to total Yair will million. XXXX are $XXX be expecting to
We you year progress. as will the update to continue
President I would Now, over turn please. in North to Shakil, our call to America. like the Shakil,